BioAtla, Inc.
BCABOTCCIK 1826892HealthcareFiscal year ends Dec 31
Reports and events: 109 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-2021:42 ET | S-1 | Registration statement | 0001539497-26-002711 |
| 2026-10-2021:33 ET | 8-K | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001193125-26-425553 |
| 2026-09-2917:16 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-26-407817 |
| 2026-08-2808:01 ET | 8-K | 3.01 Delisting notice | 0001539497-26-002373 |
| 2026-08-1317:00 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001193125-26-349542 |
| 2026-07-1616:12 ET | 8-K | 5.07 Shareholder vote results | 0001193125-26-306117 |
| 2026-06-0316:07 ET | DEF 14A | Proxy statementPeriod 2026-06-03 | 0001193125-26-255422 |
| 2026-05-1516:05 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001193125-26-226631 |
| 2026-04-2916:05 ET | 10-K/A | Annual report, amendedPeriod 2025-12-31 | 0001193125-26-191493 |
| 2026-04-0216:05 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-140053 |
| 2026-03-3116:05 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001193125-26-134499 |
| 2026-03-3116:05 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure | 0001193125-26-134501 |
| 2026-03-2316:04 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results | 0001193125-26-119698 |
| 2026-03-0207:41 ET | 8-K | 2.02 Results of operations; 2.05 Exit or disposal costs; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001539497-26-000812 |
| 2026-02-0906:01 ET | 8-K | 8.01 Other events | 0001193125-26-041852 |
| 2026-02-0617:02 ET | 8-K | 3.01 Delisting notice; 7.01 Regulation FD disclosure | 0001193125-26-041367 |
| 2026-01-3016:41 ET | 8-K | 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-031942 |
| 2026-01-1216:30 ET | 8-K | 3.02 Unregistered sale of equity; 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-010458 |
| 2025-12-3107:15 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-337646 |
| 2025-12-3016:05 ET | 8-K | 5.07 Shareholder vote results; 8.01 Other events | 0001193125-25-337078 |
| 2025-12-0516:05 ET | DEF 14A | Proxy statementPeriod 2025-12-05 | 0001539497-25-003176 |
| 2025-11-2106:15 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001193125-25-290474 |
| 2025-11-1317:00 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001193125-25-280435 |
| 2025-11-1316:06 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-280141 |
| 2025-09-2216:10 ET | 8-K | 8.01 Other events | 0001193125-25-211305 |
| 2025-08-0717:01 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0000950170-25-105220 |
| 2025-08-0716:06 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-105000 |
| 2025-06-2016:06 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results | 0000950170-25-088499 |
| 2025-05-1617:05 ET | 8-K | 3.01 Delisting notice | 0000950170-25-073688 |
| 2025-05-0617:01 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0000950170-25-064594 |
| 2025-05-0616:01 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-064415 |
| 2025-04-2416:06 ET | DEF 14A | Proxy statementPeriod 2025-04-24 | 0000950170-25-058011 |
| 2025-03-2817:44 ET | 10-K | Annual reportPeriod 2024-12-31 | 0000950170-25-046217 |
| 2025-03-2716:09 ET | 8-K | 2.02 Results of operations; 2.05 Exit or disposal costs; 9.01 Financial statements and exhibits | 0000950170-25-046065 |
| 2025-03-1416:05 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0000950170-25-039400 |
| 2025-02-0716:25 ET | 8-K | 3.01 Delisting notice | 0000950170-25-016321 |
| 2024-12-2016:51 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-24-283212 |
| 2024-12-2008:50 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-24-282547 |
| 2024-11-0717:05 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0000950170-24-123506 |
| 2024-11-0716:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-123281 |
| 2024-10-0216:30 ET | SC 13D/A | Ownership report, active investor, amended | 0001213900-24-084675 |
| 2024-09-2307:48 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193125-24-223282 |
| 2024-09-0616:59 ET | SC 13D/A | Ownership report, active investor, amended | 0001213900-24-076577 |
| 2024-08-0817:01 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0000950170-24-094164 |
| 2024-08-0816:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-093888 |
| 2024-06-1317:11 ET | 8-K | 5.07 Shareholder vote results | 0000950170-24-073139 |
| 2024-05-1716:05 ET | 8-K | 8.01 Other events | 0000950170-24-061616 |
| 2024-05-1417:01 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0000950170-24-059757 |
| 2024-05-1416:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-059508 |
| 2024-04-2416:15 ET | 8-K | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0000950170-24-047595 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 30, 2026, 06:15 ET. Listed shows no prices and gives no investment advice.